Ochratoxin a and aristolochic acid involvement in nephropathies and associated urothelial tract tumours

Arhiv za Higijenu Rada i Toksikologiju

Volumn 60, Issue 4, 2009, Pages 465-483

  Pfohl Leszkowicz, Annie ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Aetiology; Contamination; DNA adduct; Genetic polymorphism; Pathological effects; Urothelial cancer

Indexed keywords

ARISTOLOCHIC ACID; DRINKING WATER; OCHRATOXIN;

AIR POLLUTION; CARCINOGENICITY; DNA ADDUCT; EPIDEMIC; FOOD CONTAMINATION; GENETIC POLYMORPHISM; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; NONHUMAN; PATHOGENESIS; REVIEW; RISK ASSESSMENT; URINARY TRACT TUMOR; WATER CONTAMINATION;

ANIMALS; ARISTOLOCHIC ACIDS; BALKAN NEPHROPATHY; HUMANS; KIDNEY DISEASES; OCHRATOXINS; UROLOGIC NEOPLASMS;

EID: 75449084985     PISSN: 00041254     EISSN: None     Source Type: Journal    
DOI: 10.2478/10004-1254-60-2009-2000     Document Type: Review

References (128)

1. Stefanovć V. Diagnostic criteria for endemic (Balkan) nephropathy. In: Strahinjć S, Stefanovć V, edtors. Current research in endemic (Balkan) nephropathy. Niš: University Press; 1983. p. 351-363
2. Tanchev Y, Evstatiev ZV, Dorosiev G, Pencheva ZH, Zvetkov G. Prouchavaniia na nefrititev v vrachanska okolia. [Study on nephritis in the region of Vratza, in Bulgarian]. Savr Med 1956;7:14-29.
3. Danilovic V, Djurisic M, Mokranjac M, Stojimirovic B, Zivojinovic J, Stojakovic P. Chronic nephritis due to lead poisoning by digestive route (flour) [Nephrites chroniques provoquees par l'intoxication au plomb par voie digestive (farine), in French]. Presse Med 1957;65:2039-2040
4. Polenakovć M, Stefanovć V. Balkan nephropathy. In: Cameron JS, Davison AM, Grunfeld JP, Kerr D, Ritz E, editors. Oxford textbook of clinical nephrology. 1st ed. Oxford: Oxford University Press; 1992. p. 857-866
5. Chernozemsky IN, Stoyanov IS, Petkova-Bocharova TK, Nicolov IG, Draganov IV, Stoichev II, Tanchev Y, Naidenov D, Kalcheva ND. Geographic correlation between the occurrence of endemic nephropathy and urinary tract tumours in Vratza district, Bulgaria. Int J Cancer 1977;19:1-11.
6. Cukuranovć R, Ignjatovć M, Stefanovć V. Urinary tract tumors and Balkan nephropathy in the South Morava River basin. Kidney Int 1991;40(Suppl 34):S80-4.
7. Miletić-Medved M, Domijan AM, Peraica M. Recent data on endemic nephropathy and related urothelial tumors in Croatia. Wien Klin Wochensch 2005;117:604-609
8. Ceovć S, Hrabar A, Radonć M. An etiological approach to Balkan endemic nephropathy based on the investigation of two genetically different populations. Nephron 1985;40:175-179
9. Jankovć S, Marinkovć J, Radovanovć Z. Survival of the upper-urothelial-cancer patients from the Balkan nephropathy endemic and nonendemic areas. Eur Urol 1988;15:59-61.
10. Nikolć J, Djokć M, Crnomarkovć D, Marinkovć J. Upper urothelial tumors and Balkan endemic nephropathy-dose responsible diseases. Facta Univ Ser Med Biol 2002;9:114-118
11. Akhmeteli MA. Epidemiology of endemic nephropathy. In: Proceedings of the Second International Symposium on Endemic Nephropathy; 9-12 Nov 1972; Sofi a, Bulgaria. Sofi a: Bulgarian Academy of Sciences; p. 19-23.
12. Krogh P. Mycotoxic porcine nephropathy - a possible model for Balkan (endemic) nephropathy. In: Proceedings of the Second International Symposium on Endemic Nephropathy; 9-12 Nov 1972; Sofi a, Bulgaria. Sofi a: Bulgarian Academy of Sciences; p. 266-277
13. Hranjec T, Kovac A, Kos J, Mao W, Chen JJ, Grollman AP, Jelakovic B. Endemic nephropathy: the case for chronic poisoning by Aristolochia. Croat Med J 2005;46:116-125
14. Batuman V. Fifty years of Balkan endemic nephropathy: daunting questions, elusive answers. Kidney Int 2006;69:644-646
15. Cosyns JP, Goebbels RM, Liberton V, Schmeiser HH, Bieler CA, Bernard AM. Chinese herbs nephropathy associated slimming regimen induces tumours in the forestomach but no interstitial nephropathy in rats. Arch Toxicol 1998;72:738-743
16. Long DT, Voice TC. Role of exposure analysis in solving the mystery of Balkan endemic nephropathy. Croat Med J 2007;48:300-311
17. Peraica M, Domijan A-M, Saric M. Mycotoxic and aristolochic acid theories of the development of endemic nephropathy. Arh Hig Rada Toksikol 2008;59:59-65.
18. Austwick PK. Balkan nephropathy. Practitioner 1981;225:1031-1038
19. Cui M, Liu ZH, Qiu Q, Li H, Li LS. Tumour induction in rats following exposure to short-term high dose aristolochic acid I. Mutagenesis 2005;20:45-49
20. Krasteva ME, Georgieva EI. Germline p53 single-base changes associated with Balkan endemic nephropathy. Biochem Biophys Res Commun 2006;342:562-567
21. De Broe ME. On a nephrotoxic and carcinogenic slimming regimen. Am J Kidney Dis 1999;33:1171-1173
22. Xue X, Xiao Y, Gong L, Guan S, Liu Y, Lu H, Qi X, ZhangY, Li Y, Wu X, Ren J. Comparative 28-day repeated oral toxicity of Longdan Xieganwan, Akebia trifoliate (Thunb.) Koidz, Akebia quinata (Thunb.) Decne and Caulis aristolochiae manshuriensis in mice. J Ethonopharmacol 2008;119:87-93.
23. Qiu Q, Liu ZH, Chen HP, Yin HL, Li LS. Long-term outcome of acute renal injury induced by Aristolochia manshuriensis Kom in rats. Acta Pharmacol Sin 2000;21:1129-1135
24. Liu MC, Maruyama S, Mizuno M, Morita Y, Hanaki S, Yuzawa Y, Matsuo S. The nephrotoxicity of Aristolochia manshuriensis in rats is attributable to its aristolochic acids. Clin Exp Nephrol 2003;7:186-194
25. Vanherweghem LJ. Missue of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). J Altern Complement Med 1998;4:9-13.
26. Meyer MM, Chen TP, Bennett WM. Chinese herb nephropathy. BUMC Proc 2000;13:334-337
27. Boorman GA. Toxicology and carcinogenesis studies of ochratoxin A (CAS No 303-47-9) in F344/N rats (gavage studies). National Toxicology Programme, Technical Report Series 358, 1989 [displayed 12 November 2009]. Available at http://ntp.niehs.nih.gov/ntp/htdocs/LT-rpts/tr358.pdf.
28. Lock EA, Hard GC. Chemically induced renal tubule tumours in the laboratory rat and mouse: review of the NCI/NTP data base and categorization of renal carcinogens based on mechanistic information. Crit Rev Toxicol 2004;34:211-299
29. Son WC, Kamino K, Lee YS, Kang KS. Strain-specifi c mammary proliferative lesion development following lifetime oral administration of ochratoxin A in DA and Lewis rats, Int. J Cancer 2003;105:305-311
30. Castegnaro M, Mohr U, Pfohl-Leszkowicz A, Esteve J, Steinmann J, Tillmann T, Michelon J, Bartsch H. Sex- and strain-specifi c induction of renal tumors by ochratoxin A in rats correlates with DNA adduction. Int J Cancer 1998;77:70-75
31. Pfohl-Leszkowicz A, Pinelli E, Bartsch H, Mohr U, Castegnaro M. Sex- and strain-specific expression of cytochrome P450s in ochratoxin A-induced genotoxicity and carcinogenicity in rats. Mol Carcinogen 1998;23:76-85.
32. Mantle P, Kulinskaya E, Nestler S. Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A. Food Addit Contam 2005;22(Suppl 1):58-64.
33. Mantle PG. Minimum tolerable exposure period and maximum threshold dietary intake of ochratoxin A for causing renal cancer in Dark Agouti rats. Food Chem Toxicol 2009;47:2419-2424
34. Pfohl-Leszkowicz A, Castegnaro M. Further arguments in favour of direct covalent binding of Ochratoxin A (OTA) after metabolic biotransformation. Food Addit Contam 2005;22(Suppl 1):75-87.
35. Mengs U. Tumour induction in mice following exposure to aristolochic acid. Arch Toxicol 1988;61:504-505
36. EMEA, European Medicines Agency, Evaluation of Medicines for Human Use. Public Statement on the risks associated with the use of herbal products containing Aristolochia species. [displayed 12 November 2009]. Available at http://www. emea.europa.eu/pdfs/human/hmpc/13838105en.pdf.
37. Debelle FD, Nortier JL, De Prez EG, Garbar CH, Vienne AR, Salmon IJ, Deschodt-Lanckman MM, Vanherweghem JL. Aristolochic acids induce chronic renal failure with interstitial fi brosis in salt depleted rats. J Am Soc Nephrol 2002;13:431-436
38. Mengs U, Lang W, Poch JA. The carcinogenic action of aristolochic acid in rats. Arch Toxicol 1982;51:107-119
39. Mengs U. On the histopatogenesis of rat forestomach carcinoma caused by aristolochic acid. Arch Toxicol 1983;52:209-220
40. Cosyns JP, Dehoux JP, Guiot Y, Goebbels RM, Robert A, Bernard AM, van Ypersele de Strihou C. Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? Kidney Int 2001;59:2164-2173
41. Chang HR, Lian JD, Lo CW, Chang YC, Yang MY, Wang CJ. Induction of urothelial proliferation in rats by aristolochic acid through cell cycle progression via activation of cyclin D1/cdk4 and cyclin E/cdk2. Food Chem Toxicol 2006;44:28-35.
42. International Agency for Research on Cancer (IARC). Ochratoxin A. In: IARC Monographs on the evaluation of carcinogenic risks to humans. Vol 56. Geneva: IARC; 1993. p. 489-521.
43. Pfohl-Leszkowicz A, Manderville R. Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Mol Nutr Food Res 2007;51:61-99.
44. Radavanovć Z, Jankovć S, Jevremovć I. Incidence of tumours of urinary organs in a focus of Balkan endemic nephropathy. Kidney Int 1991;40(Suppl 34):75-77
45. Stoev S, Hald B, Mantle PG. Porcine nephropathy in Bulgaria: a progressive syndrome of complex or uncertain (mycotoxin) aetiology. Vet Rec 1998;142:190-194
46. Stoev S, Grozeva N, Hald B. Ultrastructural and toxicological investigations in spontaneous cases of poricine nephropathy in Bulgaria. Vet Arhiv 1998;68:39-49. (Pubitemid 128557848)
47. Stoev S, Paskalev M, MacDonald S, Mantle PG. Experimental one year ochratoxin A toxicosis in pigs. Exp Toxicol Pathol 2002;53:481-487
48. Stoev SD. Complex etiology, prophylaxis and hygiene control in mycotoxic nephropathies in farm animals and humans. Int J Mol Sci 2008;9:578-605.
49. Ceci E, Bozzo G, Bonerba E, Di Pinto A, Tantillo MG. Ochratoxin A detection by HPLC in target tissues of swine and cytological and histological analysis. Food Chem 2007;105:364-368
50. Milićevć D, Jurć V, Stefanovć S, Jovanovć M, Jankovć S. Survey of slaughtered pigs for occurrence of ochratoxin A and porcine nephropathy in Serbia. Int J Mol Sci 2008;9:2169-2183
51. Stoev SD, Vitanov S, Naguelov G, Petkova-Bocharova T, Creppy EE. Experimental mycotoxic nephropathy in pigs provoked by a mouldy diet containing ochratoxin A and penicillic acid. Vet Res Commun 2001;25:205-233
52. Stoev SD, Stefanov S, Denev S, Radć B, Domijan A-M, Peraica M. Experimental mycotoxicosis in chickens induced by ochratoxin A and penicillic acid and intervention by natural plant extracts. Vet Res Commun 2004;28:727-746
53. Diaz CT, Sogbe E, Ascanio E, Hernandez M. Ochratoxin A and fumonisin B1 natural interaction in pigs. Clinical and pathological studies. Rev Cient Fac Cien V 2001;11:314-321
54. Domijan A-M, Želježć D, Kopjar N, Peraica M. Standard and Fpg-modifed comet assay in kidney cells of ochratoxin A- and fumonisin B1-treated rats. Toxicology 2006;222:53-59
55. Kubena LF, Edrington TS, Harvey RB, Phillips TD, Sarr AB, Rottinghaus GE. Individual and combined effects o fumonisin B1 present in Fusarium moniliforme culture material and diacetoxuscirpenol or ochratoxin A in turkey poults. Poultry Sci 1997;76:256-264
56. Bernhoft A, Keblys M, Morrison E, Larsen HJS, Flaoyen A. Combined effects of selected Penicillium mycotoxins on in vitro proliferation of porcine lymphocytes. Mycopathologia 2004;158:441-450
57. Koshinsky HA, Khachatourians GG. Other forms of mycotoxicoses: the effects of mycotoxin combinations. In: Hui YH, editor. Handbook of Foodborne Diseases. Vol.2. New York (NY): Marcel Dekker Inc.; 1994. p. 463-520.
58. Pfohl-Leszkowicz A, Molinie A, Tozlovanu M, Manderville RA. Combined toxic effects of ochratoxin A and citrinin, in vitro and in vivo. In: Siantar DP, Trucksess MW, Scott PM, Herman EM, editors. Food contaminants; mycotoxins and food allergen. ACS Symposium Series. Vol.1001. Washington (DC): American Chemical Society; 2008. p. 56-80.
59. Pfohl-Leszkowicz A, Tozlovanu M, Manderville R, Peraica M, Castegnaro M, Stefanovic V. New molecular and fi eld evidences for the implication of mycotoxins but not aristolochic acid in Human Nephropathy and Urinary tract tumor. Mol Nutr Food Res 2007;51:1131-1146
60. Pfohl-Leszkowicz A, Grosse Y, Castegnaro M, Petkova- Bocharova T, Nicolov IG, Chernozemsky IN, Bartsch H, Betbeder AM, Creppy EE, Dirheimer G. Ochratoxin A related DNA adducts in urinary tract tumours of Bulgarian subjects. In: Phillips D, Castegnaro M, Bartsch H, editors. Postlabelling methods for detection of DNA adducts. IARC Scientifi c Publication 124. Lyon: IARC; 1993. p. 141-148
61. Wiessler M. DNA adducts of pyrrolizidine alkaloids, nitroimidazoles and aristolochic acid. In: Hemminki K, Dipple A, Shuker DBG, Kadulubar FF, editors. DNA adducts: identifi cation and biological signifi cance. IARC Scientifi c Publication 125. Lyon: IARC; 1995. p. 165-177
62. Manderville R, Pfohl-Leszkowicz A. Bioactivation and DNA adduction as a rationale for ochratoxin A carcinogenesis. World Mycotoxin J 2008;1:357-367
63. Tozlovanu M, Faucet-Marquis V, Pfohl-Leszkowicz A, Manderville R A. Genotoxicity of the hydroquinone metabolite of ochratoxin A: Structure-activity relationships for covalent DNA adduction. Chem Res Toxicol 2006;19:1241-1247
64. Faucet V, Pfohl-Leszkowicz A, Dai J, Castegnaro M, Manderville RA. Evidence for covalent DNA adduction by Ochratoxin A following chronic exposure to rat and subacute exposure to pig. Chem Res Toxicol 2004;17:1289-1296
65. Faucet-Marquis V, Tozlovanu M, Richard A, Manderville RA, Mantlen P, Pfohl-Leszkowicz A. Evidence by LC ms/ ms of the presence of 2'-deoxyguanosine-carbon 8-bound ochratoxin A in kidney DNA of rat fed OTA. In: EEMS 38th Annual Meeting, Environmental Mutagens and Health; 21-25 Sept 2008. Cavtat. Program and Abstracts p. 131.
66. Mantle P, Faucet-Marquis V, Manderville R, Squillaci B, Pfohl-Leszkowicz A. Structures of covalent adducts between DNA and ochratoxin A: a new factor in debate about genotoxicity and human risk assessment. Chem Res Toxicol 2010; (in press) (DOI 10.1021/tx900295a)
67. Schmeiser HH, Biehler CA, Wiessler M, van Ypersele de Strihou C, Cosyns JP. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese Herbs nephropathy. Cancer Res 1996;56:2025-2028
68. Biehler CA, Stiborova M, Wiessler M, Cosyns JP, van Ypersele de Strihou C, Schmeiser HH. 32P-psot labeling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy. Carcinogenesis 1997;18:1063-1067
69. Arlt VM, Pfohl-Leszkowicz A, Cosyns JP, Schmeiser HH. Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patient with Chinese herbs nephropathy. Mutat Res 2001;494:143-150
70. Arlt VM, Ferluga D, Stirborova M, Pfohl-Leszkowicz A, Vukelic M, Ceovic S, Schmeiser HH, Cosyns JP. Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer? Int J Cancer 2002;101:500-502
71. Grollman AP, Shibutani S, Moriya M, Miller F, Wu L, Moll U, Suzuki N, Fernandes A, Rosenquist T, Medverec Z, Jakovina K, Brdar B, Slade N, Turesky RJ, Goodenough AK, Rieger R, Vukelić M, Jelakovć B. Acid aristolochic and the etiology of endemic (Balkan) nephropathy. Proc Natl Acad Sci USA 2007;104:12129-12134
72. Arlt VM, Alunni-Perret V, Quatrehomme G, Ohayon P, Albano L, Gaid H, Michiels JF, Meyrier A, Cassuto E, Wiessler M, Schmeiser HH, Cosyns JP. Aristolochic acid (AA-)-DNA addcut as marker of AA exposure and risk factor for AA nephropathy-associated cancer. Int J Cancer 2004;111:977-980
73. Stengel B, Jones E. Insuffi sance renale terminale associee a la consommation d'herbes chinoises en France [End-stage renal failure associated with chinese herbs in France, in French]. Nephrologie 2004;19:15-20.
74. Pfohl-Leszkowicz A. Formation, persistence and signifi cance of DNA adduct formation in relation to some pollutants from a board perspective. Adv Toxicol 2008;2:183-240.
75. Malak J. Chinese herb nephropathy is not a (dex)fenfluramine nephropathy but a serotonin nephropathy. J Altern Complement Med 1998;4:131-135
76. Atanasova SY, von Ahsen N, Toncheva D, Dimitrov TG, Oellerich M, Armstrong VW. Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN). Clin Biochem 2005;38:223-228
77. Givens R, Lin Y, Dowling A, Thummel KE, Lamba JK, Schuetz EG, Stewart PW, Watkins PB. CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults. J Appl Physiol 2003;95:1297-1300.
78. Lamba JK, Lin YS, Schuetz EG, Thummel KE. Genetic contribution to variable human CYP3A-mediated metabolism. Adv Drug Deliv Rev 2002;54:1271-1294
79. Plant N. The human cytochrome P450 sub-family: Transcriptional regulation, inter-individual variation and interaction networks. Biochim Biophys Acta 2007;1770:478-488
80. Nikolov IG, Chernozemsky IN, Idle JR. Genetic predisposition to Balkan endemic nephropathy: Ability to hydroxylate debrisoquine as a host risk factor. In: Bartsch H, Dirheimer G, Categnaro M, Pleština R, Chernozemsky IN, editors. Mycotoxins, endemic nephropathy and urinary tract tumours. IARC Scientifi c Publication 115. Lyon: IARC; 1991. p. 289- 296
81. Schaaf GJ, Nijmeijer SM, Maas RFM, Roestenberg P, de Groene EM, Fink-Gremmels J. The role of oxidative stress in the ochratoxin A mediated toxicity in proximal tubular cells. Biochim Biophys Acta 2002;1588:149-158 (Pubitemid 35217838)
82. El Adlouni C, Pinelli E, Azemar B, Zaoui D, Beaune P, Pfohl- Leszkowicz A. Role of CYP 2C and microsomal glutathione- S-transferase in modulating susceptibility to ochratoxin A genotoxicity. Environ Mol Mutagen 2000;35:123-131
83. Katoh T. Application of molecular biology to occupational health field-the frequency of gene polymorphism of cytochrome P450 1A1 and glutathione S-transferase M1 in patient with lung, oral and urothelial cancer. J UOEH 1995;17:271-278
84. Aktas D, Ozen H, Atsu N, Tekin A, Sozen S, Tuncbilek E. Glutathione-S-transferase M1 gene polymorphism in bladder cancer patient. A marker for invasive bladder cancer? Cancer Genet Cytogenet 2001;125:1-4.
85. Longuemaux S, Delomenie C, Gallou C, Mejean A, Vincent- Viry M, Bouvier R, Droz D, Krishnamoorthy R, Galteau MM, Junien C, Beroud C, Dupret JM. Candidate genetic modifi ers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes. Cancer Res 1999;59:2903-2908
86. Steinhoff C, Franke FH, Golka,K, Their R, Romer HC, Rotzel C, Ackerman R, Schulz WA. Glutathione transferase isoenzyme genotypes in patients with prostate and bladder carcinoma. Arch Toxicol 2000;74:521-526
87. Andonova IE, Sarueva RB, Horvath AD, Simeonov VA, Dimitrov PS, Petropoulos EA, Ganev lkan VS. Endemic nephropathy and genetic variants of glutathione Stransferases. J Nephrol 2004;17:390-398
88. Lash LH, Andrews MW. Cytotoxicity of S-(1,2-dichlorovinyl) glutathione and S-(1,2dichlorovinyl)-L-cysteine in isolated rat kidney cells. J Biol Chem 1986;261:13076-13081
89. van Bladeren PJ. Glutathione conjugation as a bioactivation reaction. Chem Biol Interact 2000;129:61-76.
90. Pfohl-Leszkowicz A, Bartsch H, Azemar B, Mohr U, Esteve J, Castegnaro M. MESNA protects rats against nephrotoxicity but not carcinogenicity induced by ochratoxin A, implicating two separate pathways. Facta Universitatis, Ser Med Biol 2002;9:57-63.
91. Faucet-Marquis V, Pont F, Stormer F, Rizk T, Castegnaro M, Pfohl-Leszkowicz A. Evidence of a new dechlorinated OTA derivative formed in opossum kidney cell cultures after pre-treatment by modulators of glutathione pathways. Correlation with DNA adducts formation. Mol Nutr Food Res 2006;50:531-542
92. Hartge P, Hoover R, West DW, Lyon JL. Coffee drinking and risk of bladder cancer. J Natl Cancer Inst 1983;70:1021-1026
93. Lebrun S, Golka K, Schulze H, Follman W. Glutathione S-transferase polymorphisms and ochratoxin A toxicity in primary human urothelial cells. Toxicology 2006;224:81-90.
94. Ringot D, Chango A, Schneider YJ, Larondelle Y. Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem Biol Interact 2006;159:18-46.
95. Kurashi N, Inoue M, Iwasaki S, Sasazuki S, Tsugane S. Coffee, green tea and caffeine consumption and subsequent risk of bladder cancer in relation to smoking status: a prospective study in Japan. Cancer Sci 2009;100:284-291
96. Covolo L, Placide D, Gelatti U, Carta A, Di Carlo AS, Lodetti P, Picciche A, Orizi G, Campagna M, Arici C, Dorru S. Bladder cancer, GSTs, NAT1, NAT2, sult 1A1, XRRC1, XRRC3, XPD genetic polymorphisms and coffee consumption: a case control study. Eur J Epidemiol 2008;23:355-362
97. Pfohl-Leszkowicz A, Petkova-Bocharova T, Chernozemsky IN, Castegnaro M. Balkan endemic nephropathy and associated urinary tract tumours: a review on aetiological causes and the potential role of mycotoxins. Food Addit Contam 2002;19:282-302.
98. Mayer S, Curtui V, Usleber E, Gareis M. Airborne mycotoxins in dust of grain elevators. Mycotoxin Res 2007;23:94-100.
99. Nguyen MT, Tozlovanu M, Tran TL, Pfohl-Leszkowicz A. Occurrence of aflatoxin B1, citrinin and ochratoxin A in rice in five provinces of the central region of Vietnam. Food Chem 2007;105:42-47
100. Levi CP, Trenk HL, Mohr HK. Study of the occurrence of ochratoxin A in green coffee beans. J Assoc Off Anal Chem 1974;57:866-870
101. Blanc M, Pittet A, Munoz-Box R, Viani R. Behavior of ochratoxin A during green coffee roasting and soluble coffee manufacture. J Agric Food Chem 1998;46:673-675
102. International Coffee Organization (ICO). OTA risk management: guidelines for green coffee buying [displayed 12 November 2009]. Available at http://www.ico.org/ documents/ed1939e.pdf.
103. Domijan A-M, Peraica M, Jurjevć Z, Ivć D, Cvjetkovć B. Fumonisin B1, fumonisin B2, zearalenone and ochratoxin A contamination of maize in Croatia. Food Addit Contam 2005;22:677-680 (Pubitemid 40990584)
104. Jurjevć L, Solfrizzo M, Cvjetkovć B, de Girolamo A, Visconti A. Ocurrence of beauvericin in corn from Croatia. Food Technol Biotechnol 2002;40:91-94
105. Vrabcheva T, Usleber E, Dietrich R, Martlbauer E. Cooccurrence of ochratoxin A and citrinin in cereals from Bulgarian villages with a history of Balkan endemic nephropathy. J Agric Food Chem 2000;48:2483-2488
106. Petkova-Bocharova T, Castegnaro M, Michelon J, Maru V. Ochratoxin A and other mycotoxins in cereals from an area of Balkan endemic nephropathy and urinary tract tumours in Bulgaria. In: Bartsch H, Dirheimer G, Categnaro M, Pleština R, Chernozemsky IN, editors. Mycotoxins, endemic nephropathy and urinary tract tumours. IARC Scientifi c Publication 115. Lyon: IARC; 1991. p. 83-87
107. Petkova-Bocharova T, Castegnaro M, Pfohl-Leszkowicz A, Garren L, Grosso F, Nikolov I, Vrabcheva T, Dragacci S, Chernozemsky I. Analysis of ochratoxin A in serum and urine of inhabitants from an area with Balkan Endemic Nephropathy: A one month follow up study. Facta Universitatis, Ser Med Biol 2003;10:62-68
108. Di Paolo N, Guarinieri A, Loi F, Sacchi G, Mangiarotti AM, Di Paolo M. Acute renal failure from inhalation of mycotoxins. Nephron 1993;64:621-625
109. Skaug MA, Helland I, Solvoll K, Saugstad OD. Presence of ochratoxin A in human milk in relation to dietary intake. Food Addit Contam 2001;18:321-327
110. Skaug MA, Eduard W, Stormer FC. Ochratoxin in airborne dust and fungal conidia. Mycopathologia 2001;151:93-98
111. Brera C, Caputi R, Miraglia M, Iavicoli I, Salerno A, Carelli G. Exposure assessment to mycotoxins in workplaces: aflatoxins and ochratoxin A occurrence in airborne dusts and human sera. Microchem J 2002;73:167-173
112. Iavicoli I, Brera C, Carelli G, Caputi RM, Marinaccio A, Miraglia M. External and internal dose in subjects occupationally exposed to ochratoxin A. Int Arch Occup Environ Health 2002;75:381-386
113. Gareis M, Meussdoerffer F. Dust of grains and malts as a source of ochratoxin A exposure. Mycotoxin Res 2000;16:127-130
114. Wang Y, Chai T, Lu G, Quan C, Duan H, Yao M, Zucker B-A, Schlenker G. Simultaneous detection of airborne aflatoxin, ochratoxin and zearalenone in a poultry house by immunoaffi nity clean-up and high-performance liquid chromatography. Environ Res 2008; 107 139-144
115. Abramson D, Hulasare R, White NDG, Jayas DS, Marquadt RR. Mycotoxin formation in hullness barley during granary storage at 15% and 19% moisture content. J Stored Prod Res 1999;35:297-305.
116. Chandelier A, Michelet JY, Tangni EK, Baert K, Moons E, Vinkx C. Mycotoxins survey in Belgium and toxigenic Fusarium in Belgian wheat. In: Logrieco A, Visconti A, editors. An overview on toxinogenic fungi and mycotoxins in Europe. Amsterdam: Kluwer Academic Publishers; 2004. p. 11-32.
117. Tangni EK, Pussemier L. Ochratoxin A and citrinin loads in stored wheat grains: impact of grain dust and possible prediction using ergosterol measurement. Food Addit Contam,2006;23:181-189
118. Pussemier L, Larondelle Y, van Peteghen C, Huyghebaert A. Chemical safety of conventionally and organically produced foodstuffs: A tentative comparison under Belgian conditions. Food Control 2006;17:14-21.
119. Dacarro C, Grisoli P, del Frate G, Villani S, Grignani E, Cottica D. Micro-organisms and dust exposure in an OItalian grain mill. J Appl Microbiol 2005;98:163-171
120. Halstensen AS, Nordby KC, Klemsdal SS, Elen O, Eduard W. Ochratoxin A in grain dust: estimated exposure and relations to agricultural practices in grain production. Ann Agric Environ Med 2004;11:245-254
121. Macgeorge KM, Mantle PG. Nephrotoxicity of Penicillium aurantiogriseum and P. commune from an endemic area of Yugoslavia. Mycopathologia 1990;112:139-145
122. Pereira VJ, Basilio MC, Fernandes D, Domingues M, Paiva JM, Benoliel MJ, Crespo MT, San Romao MV. Occurrence of fi lamentous fungi and yeasts in three different drinking water sources. Water Res 2009;43:3813-3819
123. Paterson RRM, Kelley J, Gallagher M. Natural occurrence of aflatoxins and Aspergillus flavus (link) in water. Lett App Microbiol 1997;25:435-436
124. Kuiper-Goodman T, Richard I, Kiparissis Y. Trends in exposure to ochratoxin A suggest a plausible role for this mycotoxin in the development of Balkan endemic nephropathy. In: Proceeding of the workshop "Recent advances in Balkan endemic nephropathy research"; 16-18 April 2009. Belgrade: Serbian Academy of Sciences and Arts; 2009.
125. Walker R. Mycotoxins of growing interest. Third joint FAO/ WHO/UNEP International Conference on Mycotoxins, Tunis 1999 [displayed 12 November 2009]. Available at ftp://ftp. fao.org/es/esn/food/myco5b.pdf.
126. Kuiper-Goodman T, Scott PM. Risk assessment of the mycotoxin ochratoxin A. Biomed Environ Sci 1989;2:179-248.
127. Manderville RA. Ambident reactivity of phenoxyl radicals in DNA adduction. Can J Chem 2005;83:1261-1267
128. Scott PM, Kanhere SR, Lau BP, Lewis DA, Hayward S, Ryan JJ, Kuiper-Goodman T. Survey of Canadian human blood plasma for ochratoxin A. Food Addit Contam 1998;5:555-562